# Question 55

**Type:** Survival Analysis

**Question:** What is the median survival time in the Pediatric Neuroblastoma study from TARGET?

**Answer:**

## Answer

Based on the cBioPortal data for the **Pediatric Neuroblastoma (TARGET, 2018)** study:

**The median overall survival time is 54.5 months** (approximately 4.5 years).

### Additional Survival Statistics:

- **Total patients with survival data:** 1,072
- **Mean survival:** 57.66 months
- **Range:** 1.0 to 183.0 months
- **Interquartile range (IQR):**
  - 25th percentile (Q1): 28.0 months
  - 75th percentile (Q3): 78.0 months

### Survival Status Distribution:
- **Living:** 675 patients (63%)
- **Deceased:** 397 patients (37%)

This data represents whole genome or whole exome sequencing on 1,089 neuroblastoma samples from the TARGET (Therapeutically Applicable Research to Generate Effective Treatments) initiative, published in 2018.

---

## Model Information
- **agent_type**: mcp-clickhouse
- **model**: anthropic:claude-sonnet-4-5-20250929
- **use_ollama**: False
- **ollama_base_url**: http://localhost:11434
- **max_tokens**: 4096

---

*Generated on 2026-02-05 02:30:13*